Tsung-Min Hsu

Title: Innovations of Tsung-Min Hsu

Introduction

Tsung-Min Hsu is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of transdermal drug delivery systems. With a total of 8 patents to his name, Hsu's work focuses on improving the efficacy and stability of drug delivery methods.

Latest Patents

Hsu's latest patents include a method for producing an active ingredient for a rivastigmine free base transdermal patch. This invention involves preparing a rivastigmine free base and adding an acidic substance to create a mixture with a pH value between 6.0 and 8.5. The resulting transdermal patch allows for a stable transmission time of rivastigmine free base for up to 168 hours. Another significant patent is a two-phase matrix for sustained release drug delivery devices. This matrix consists of a continuous hydrophobic polymer phase and a dispersed particulate hydrated inorganic silicate, enhancing drug permeation through the skin.

Career Highlights

Throughout his career, Hsu has worked with various organizations, including Cygnus, Inc. and the University of Utah Research Foundation. His innovative approaches have led to advancements in drug delivery technologies.

Collaborations

Hsu has collaborated with notable individuals such as Robert V Petersen and Eric J Roos, contributing to the development of effective drug delivery systems.

Conclusion

Tsung-Min Hsu's contributions to the field of transdermal drug delivery are noteworthy. His innovative patents and collaborations have significantly advanced the effectiveness of drug delivery methods.